December 12, 2018December 12, 2018

4MGS Test Predicts IPF Patient Mortality, Hospitalization, Study Says

News

Gait speed, measured by the four meter gait speed (4MGS) test, is an independent predictor of all-cause mortality and hospitalization in patients with idiopathic pulmonary fibrosis (IPF), according to ... Read more

December 11, 2018December 7, 2018

Self-compassion Helps Us Deal with Pulmonary Fibrosis

Columns, Just Breathe...Compassionate Help for the PF Journey

Pulmonary fibrosis patients need all the compassion we can get. It turns out that the most important person to give us compassion is … ourselves! A growing body of ... Read more

December 11, 2018December 11, 2018

Nasal Sampling May Be Fast and Noninvasive Way to Identify and Manage IPF, Study Suggests

News

The nasal epithelium of patients with idiopathic pulmonary fibrosis (IPF) shows different levels of gene expression implicated in inflammatory and immune responses than those without the disease, a study ... Read more

December 10, 2018December 10, 2018

Veracyte Expands Early Access to Envisia Genomic Classifier Test for IPF Diagnosis

News

Veracyte recently announced the expansion of an early access program offering the Envisia Genomic Classifier test for the diagnosis of idiopathic pulmonary fibrosis (IPF). In the U.S., 20 medical centers ... Read more

December 7, 2018December 11, 2018

Esbriet Extends IPF Patient Survival, Real-world Study Reports

Esbriet, News

Esbriet (pirfenidone) can improve survival rates of idiopathic pulmonary fibrosis (IPF) patients by 30 percent, a real-world retrospective analysis shows. The study, “Pirfenidone improves survival in IPF: results from a ... Read more

December 6, 2018December 4, 2018

Tips to Conserve Energy During Holiday Gatherings

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

With the holiday season upon us, the social gatherings have begun. An unofficial start to the holidays for me is attending my family Christmas dinner, which occurs on the ... Read more

December 5, 2018December 5, 2018

Nuformix’s NXP002 Candidates Show Potential Against IPF in ‘In-Patient’ Preclinical Model

News

Preclinical data show that treatment with Nuformix’s investigational candidates within the NXP002 program can prevent fibrosis progression with enhanced efficiency compared to the current standard of care, the company ... Read more

December 4, 2018December 7, 2018

Using Technology to Get Help

Columns, Just Breathe...Compassionate Help for the PF Journey

Over a month ago, one of our readers, Mardy Sitzer, shared a wonderful idea with me. She graciously permitted me to share it with you. Like many of us, ... Read more

December 4, 2018December 4, 2018

Late-stage IPF Patients Have Progressively Worse Quality of Life, Real-world Study Reports  

News

Idiopathic pulmonary fibrosis (IPF) patients experience a significant decline in quality of life and worse symptom burden during the last months of life, a real-world study shows. The Finland-based ... Read more

December 3, 2018November 30, 2018

A Gratitude Miniseries: November 2018

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

With November coming to a close, I look forward to sharing with you the things I am grateful for as part of my continuing miniseries on gratitude. As I turn ... Read more

December 3, 2018December 5, 2018

Potential Anti-Fibrotic Oral Treatment, RXC006, Shows Promise in Early Studies, Redx Announces

News

RXC006, an oral treatment candidate for idiopathic pulmonary fibrosis (IPF) and other types of fibrosis, was seen to ease lung scarring in a mouse model of IPF, its developer, Redx Pharma, ... Read more

November 30, 2018December 4, 2018

Reduced Lung Function Linked to Increased Risk of Dementia, Cognitive Impairment, Study Reveals

News

Middle-age adults with reduced respiratory function have up to a 27% higher risk of developing dementia or cognitive impairment later in life, a study suggests. This risk pattern is even ... Read more